Search - tctmd.com

Displaying 61 - 80 of 362

Sort: Relevancy | Date

News Conference News ACC 2024

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Yael L. Maxwell

July 03, 2024

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

ApoB Can Be High, Risky for ASCVD Even When LDL’s Normal

Yael L. Maxwell

June 17, 2024

News Daily News

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

Todd Neale

May 31, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

Presentation ACC 2024

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Presenter: Eric Quinton Klug

April 07, 2024

News Conference News ACC 2024

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

Shelley Wood

April 07, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank

Michael O'Riordan

January 23, 2024

News Daily News

Less Is More: Lp(a) Much More Atherogenic Than LDL

Michael O'Riordan

January 16, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Michael O'Riordan

December 19, 2023

News Daily News

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Yael L. Maxwell

December 15, 2023

Advertisement

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

ApoB Can Be High, Risky for ASCVD Even When LDL’s Normal

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Statins Effective For Primary Prevention in Old and Very Old

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

What’s Going to Be Hot at ACC 2024

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank

Less Is More: Lp(a) Much More Atherogenic Than LDL

Top General Cardiology and CVD Prevention News of 2023

Top Coronary Artery Disease News of 2023

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content